These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 3540770)

  • 1. Clinical and immunological results of corneal allograft rejection.
    Smiddy WE; Stark WJ; Young E; Klein PE; Bias WD; Maumenee AE
    Ophthalmic Surg; 1986 Oct; 17(10):644-9. PubMed ID: 3540770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO; Price FW
    Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological aspects of corneal graft rejection and own experience in immunosuppressive therapy in high risk patients].
    Kamińska A; Szaflik J; Minkiewicz-Timler G; Sybilska M; Pawluczyk-Dyjecińska M; Smolarek M
    Klin Oczna; 2004; 106(3 Suppl):485-8. PubMed ID: 15636244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of predictors of long-term cadaveric renal allograft survival.
    Cole E; Naimark D; Aprile M; Wade J; Cattran D; Pei Y; Fenton S; Robinette M; Zaltsman J; Bear R
    Clin Transplant; 1995 Aug; 9(4):282-8. PubMed ID: 7579734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of late allograft nephrectomy.
    Madore F; Hébert MJ; Leblanc M; Girard R; Bastien E; Morin M; Beaudry C; Boucher A; Dandavino R
    Clin Nephrol; 1995 Nov; 44(5):284-9. PubMed ID: 8605707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival.
    Gonzalez-Stawinski GV; Cook DJ; Chang AS; Banbury MK; Navia JL; Hoercher K; Lober C; Atik FA; Taylor DO; Yamani MH; Young JB; Starling RC; Smedira NG
    J Heart Lung Transplant; 2006 Jun; 25(6):613-8. PubMed ID: 16730565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of donor storage time on corneal allograft survival.
    Simon M; Fellner P; El-Shabrawi Y; Ardjomand N
    Ophthalmology; 2004 Aug; 111(8):1534-8. PubMed ID: 15288984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
    J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction therapy with thymoglobulin after heart transplantation: impact of therapy duration on lymphocyte depletion and recovery, rejection, and cytomegalovirus infection rates.
    Goland S; Czer LS; Coleman B; De Robertis MA; Mirocha J; Zivari K; Schwarz ER; Kass RM; Trento A
    J Heart Lung Transplant; 2008 Oct; 27(10):1115-21. PubMed ID: 18926403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rejection after simultaneous pancreas-kidney transplantation.
    Arbogast H; Malaise J; Illner WD; Tarabichi A; Dieterle C; Landgraf R; Land W;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury.
    Bogetti D; Sankary HN; Jarzembowski TM; Manzelli A; Knight PS; Thielke J; Chejfec G; Cotler S; Oberholzer J; Testa G; Benedetti E
    Clin Transplant; 2005 Aug; 19(4):507-11. PubMed ID: 16008596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Completely reversed acute rejection episodes do not influence the long-term renal allograft survival].
    Wu JY; Chen JH; Wang YM; Zhang JG; Zhu C; Wang SY; Zhang P; Huang HF; He Q
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):106-9. PubMed ID: 12812676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part two: the statistical analysis of probability and risk factors.
    Price MO; Jordan CS; Moore G; Price FW
    Br J Ophthalmol; 2009 Mar; 93(3):391-5. PubMed ID: 19019938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.
    McVicar JP; Kowdley KV; Emond MJ; Barr D; Marsh CL; Carithers RL; Perkins JD
    Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
    Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
    Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.